Buscar | Webyourself Social Media Platform

Sushil Sushil agrega un archivo Other
2024-02-23 05:05:20 -

Primary Sclerosing Cholangitis Market Is Driven By Increasing Drug Approvals
The primary sclerosing cholangitis (PSC) market overview comprises growing prevalence of autoimmune and inflammatory liver diseases globally. Primary sclerosing cholangitis is a chronic condition that causes progressive inflammation and scarring of bile ducts in the liver. Some key symptoms include fatigue, jaundice and itching. Current treatment involves management of symptoms,...

0 Commentarios 0 Acciones 1292 Views 0 Vista previa

Please log in to like, share and comment!
Kirti Narayankar agrega un archivo Other
2024-06-12 05:13:14 -

Primary Sclerosing Cholangitis Market Size, Share, Demand, Future Growth, Challenges and Competitive Analysis
"Recent study report released by Data Bridge Market research titled Global Primary Sclerosing Cholangitis Market (covering USA, Europe, China, Japan, India, South East Asia and etc) that highlighting opportunities, risk analysis, and leveraged with strategic and tactical decision-making support. A top notch Primary Sclerosing Cholangitis market analysis report contains the recent industry...

0 Commentarios 0 Acciones 643 Views 0 Vista previa

Please log in to like, share and comment!
Niranjan Maradakar agrega un archivo Other
2024-01-17 10:19:25 -

Primary Sclerosing Cholangitis Market Estimated to Witness High Growth Owing to Increasing Disease Prevalence
Primary sclerosing cholangitis (PSC) is a chronic progressive liver disease that causes inflammation and scarring of the bile ducts. It is currently one of the leading causes of liver disease and transplantation in the developed world. PSC is a long-term condition with no cure where the bile ducts inside and outside the liver become inflamed and scarred over time, restricting the flow of bile....

0 Commentarios 0 Acciones 1306 Views 0 Vista previa

Please log in to like, share and comment!
Pooja Salve agrega un archivo Health
2023-12-22 04:02:03 -

Primary Sclerosing Cholangitis Market Estimated to Witness High Growth Owing to Promising Pipeline Drugs
SWOT Analysis Strength: Primary sclerosing cholangitis (PSC) has diagnostic tests that help confirm a diagnosis such as magnetic resonance cholangiopancreatography (MRCP) which produces detailed images of the bile ducts and pancreatic ducts without using radiation. Endoscopic retrograde cholangiopancreatography (ERCP) also helps in diagnosing PSC by examining the bile ducts and detects...

0 Commentarios 0 Acciones 1329 Views 0 Vista previa

Please log in to like, share and comment!
Dbmr Healthcare agrega un archivo Health
2023-07-19 09:12:42 -

Primary Sclerosing Cholangitis Market Focuses on Key Drivers and Opportunities by 2028
All studies and projections included in the process of conventional market research analysis are covered in the Primary Sclerosing Cholangitis market business report. A flawless market research report is required for actionable market intelligence and profitable business strategies. This market study provides a thorough review of product type, technology, and production analysis by...

0 Commentarios 0 Acciones 1748 Views 0 Vista previa

Please log in to like, share and comment!
Pooja Salve agrega un archivo Health
2023-10-30 13:15:04 -

Primary Sclerosing Cholangitis Market Growth Owing To Increasing Prevalence And Lack Of Cure
SWOT Analysis Strength: - Increasing research and development activities for developing effective therapeutics is expected to drive the market growth. Several clinical trials are being conducted to evaluate drug candidates.- Rising awareness regarding primary sclerosing cholangitis is positively impacting the market. Various non-profit organizations are conducting awareness programs.-...

0 Commentarios 0 Acciones 1451 Views 0 Vista previa

Please log in to like, share and comment!
Dhanashri Patil agrega un archivo Health
2024-02-19 07:03:22 -

Primary Sclerosing Cholangitis Market is Anticipated to Witness Moderate Growth Owing to Increasing Research Funding and Innovation in Drugs
The primary sclerosing cholangitis market comprises drugs and treatments to manage the symptoms of primary sclerosing cholangitis, a rare disorder that causes inflammation and scarring in the bile ducts of the liver. Primary sclerosing cholangitis (PSC) is a rare long-term disease that causes narrowing and scarring of the bile ducts inside and outside the liver. Patients with PSC experience...

0 Commentarios 0 Acciones 979 Views 0 Vista previa

Please log in to like, share and comment!
Ashwini Bakhade agrega un archivo Other
2024-03-20 10:40:29 -

Primary Sclerosing Cholangitis: A Rare but Serious Liver Disease
What is Primary Sclerosing Cholangitis?Primary sclerosing cholangitis (PSC) is a rare and chronic disease characterized by inflammatory destruction and scarring of the bile ducts within the liver. The bile ducts are thin tubes that carry bile from the liver to the small intestine. In PSC, the bile ducts become inflamed, scarred, and narrowed over time. This causes a blockage of the normal flow...

0 Commentarios 0 Acciones 1041 Views 0 Vista previa

Please log in to like, share and comment!
Raj Kumar Dhote agrega un archivo Health
2024-03-04 13:42:43 -

Primary Sclerosing Cholangitis: An Autoimmune Disorder Causing Liver Damage
Primary sclerosing cholangitis (PSC) is a chronic progressive disease of the bile ducts that can lead to scarring damage and cirrhosis of the liver if left untreated. In this article, we will explore what PSC is, what causes it, typical symptoms and diagnosis, treatment options, and living with the disease. What is Primary Sclerosing Cholangitis?Primary sclerosing cholangitis (PSC) is an...

0 Commentarios 0 Acciones 1033 Views 0 Vista previa

Please log in to like, share and comment!
Sneha CMI agrega un archivo Health
2023-11-06 13:08:24 -

The burgeoning Primary Sclerosing Cholangitis market poised to exhibit steady
The Primary Sclerosing Cholangitis Market is estimated to be valued at US$ 3,604.7 Mn in 2022 and is expected to exhibit a CAGR of 4.6% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. SWOT Analysis:- · Strengths: Growing research and development activities for improved treatment...

0 Commentarios 0 Acciones 1476 Views 0 Vista previa

Please log in to like, share and comment!
Raj Kumar Dhote agrega un archivo Other
2023-12-18 14:31:37 -

Primary Sclerosing Cholangitism Market Is Estimated To Witness High Growth Owing To Rising Disease Prevalence
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by multifocal fibrosis of both intra- and extra-hepatic bile ducts. It is associated with ulcerative colitis in 70–80% of cases. The disease course is variable but often progresses to end-stage liver disease leading to liver transplantation. Currently, there is no approved medical treatment for PSC....

0 Commentarios 0 Acciones 1237 Views 0 Vista previa

Please log in to like, share and comment!

Resultados de la búsqueda